Skip to main content

Table 3 Performance of the radiomics–clinical nomogram in discriminating between lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) in both training and validation cohorts

From: Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer

Cohort

Sena

Spea

Acca

AUCa

95% CI

p value

Lower

Upper

Training

90.0%

76.0%

83.0%

0.901

0.842

0.960

< 0.05

Validation

88.9%

73.3%

79.2%

0.872

0.779

0.965

< 0.05

  1. aSen, Spe, Acc and AUC indicate the sensitivity, specificity, accuracy and area under the curve of the receiver operating characteristic curve, respectively